Sanuvox has been acquired by BDG & Partners
The owners of Sanuvox Technologies Inc. have sold the company to BDG & Partners.
Established in 1995 in Montreal, Sanuvox is a global leader in ultraviolet air purification, providing the most advanced cost-effective in-duct and stand-alone UV air and coil disinfection systems available. Sanuvox's proprietary UV systems are designed to maximize exposure time, delivering the ultraviolet energy required for exceptionally high airborne sterilization rates. In-duct and stand-alone Sanuvox systems are used around the world in residential, commercial, medical and cannabis installations.
BDG is a Canadian private equity firm that aims to create value by investing in great businesses where its capital, strategic insight, global relationships and operational experience can contribute to the company’s further growth.
Oaklins’ team in Canada acted as advisor to the seller in this transaction.


Talk to the deal team
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more